Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification.
Kushner
Brian H
BH
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA. kushnerb@mskcc.org
LaQuaglia
Michael P
MP
Modak
Shakeel
S
Cheung
Nai-Kong V
NK
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007223:Infant; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D000071447:N-Myc Proto-Oncogene Protein; D009447:Neuroblastoma / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D009687:Nuclear Proteins / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D012186:Retroperitoneal Neoplasms / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D015275:Tumor Lysis Syndrome / Q000209:etiology
C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D007770:L-Lactate Dehydrogenase